This week, new research suggests 99.999 percent of the deep ocean has never been observed by humans, a new species of ...

Sustained-release naltrexone may slightly increase illicit opioid use and serious adverse events compared to opioid agonists, with uncertain effects on retention and acceptability. It may reduce ...

AMSTERDAM — A once daily, 50 mg dose of efruxifermin reduced fibrosis at 96 weeks in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) compared with ...

All of which is to say that I don't lack for morning energy. I do make a cup of coffee, but it is as much about the process ...

Linerixibat, an investigational oral ileal bile acid transporter (IBAT) inhibitor, improved cholestatic pruritus in patients ...

With a demand that vaccine boosters be tested against placebos, RFK Jr. puts an old antivaccine claim at the forefront of government health policy.

GSK has shared the data behind its phase 3 liver disease win, revealing patients on linerixibat reported reductions in ...

At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals First Quarter Earnings Conference Call. All participants will be in a listen-only mode. After today’s presentation there ...

The nocebo effect appears to work more strongly and more persistently than the placebo effect when it comes to pain, a new study has found. In other words, having negative expectations going into a ...

Cardiovascular disease remains a leading cause of morbidity and mortality worldwide, with atherosclerotic cardiovascular ...

A blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.

Health and Human Services Secretary Robert F. Kennedy Jr. has misleadingly claimed that vaccines are not tested in ...